Lakewood-based Terumo Blood and Cell Technologies (Terumo BCT) has announced the establishment of its new Global Therapy Innovations business unit. The unit aims to integrate disease expertise throughout the patient journey, from cell collections to therapy delivery, and is led by Veerle d’Haenens, general manager, Global Therapy Innovations. The initiative intends to enhance standards of…